Immune-related adverse events for patients with lung cancer-volume II

被引：0

作者：

Wang, Yusha ^{[1
,2
]}

Wang, Xia ^{[3
]}

Zhan, Cheng ^{[4
]}

Frey, Benjamin ^{[5
]}

Gaipl, Udo S. ^{[5
]}

Shi, Hubing ^{[1
,2
]}

Ma, Xuelei ^{[1
,2
]}

机构：

[1] Sichuan Univ, West China Hosp, Canc Ctr, Dept Biotherapy, Chengdu, Sichuan, Peoples R China

[2] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China

[3] Sichuan Univ, West China Hosp, Dept Biotherapy Res, Chengdu, Sichuan, Peoples R China

[4] Fudan Univ, Zhongshan Hosp, Dept Thorac Surg, Shanghai, Peoples R China

[5] Dept Radiat Oncol, Univ Klinikum Erlangen, Erlangen, Germany

来源：

FRONTIERS IN ONCOLOGY | 2023年 / 13卷

关键词：

immune-related adverse events (irAEs); immune checkpoint inhibitors (ICIs); Immunotherapy; lung cancer; editorial;

D O I：

10.3389/fonc.2023.1282394

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：2